Perturbations du comportement secondaires aux troubles neurocognitifs (SCPD) : Évaluation et prise en charge globale #089

Ballard, C. G., Thomas, A., Fossey, J., Lee, L., Jacoby, R., Lana, M. M., . . . O’Brien, J. T. (2004). A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. J Clin Psychiatry, 65(1), 114-119. http://www.ncbi.nlm.nih.gov/pubmed/14744180